Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
about
Eradication of measles: remaining challengesRisks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events.Asthma status and waning of measles antibody concentrations after measles immunization.Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among childrenPrevention of measles virus infection by intranasal delivery of fusion inhibitor peptidesProfiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.Variability in Humoral Immunity to Measles Vaccine: New Developments.Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of ageThe genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesMeasles Outbreak Associated With Low Vaccine Effectiveness Among Adults in Pohnpei State, Federated States of Micronesia, 2014In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.Measles vaccine: Past, present, and future.Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose.Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.Waning immunity against mumps in vaccinated young adults, France 2013.The Reemergence of Measles.Environmental tobacco exposure is associated with vaccine modified measles in junior high school students.Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.Text message reminders for timely routine MMR vaccination: A randomized controlled trial.Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.The epidemiological and clinical characteristics of measles in Wenzhou, China, 2000-2010.Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to August 2015.Exploring gaps in surveillance of a small measles outbreak in Toronto, Canada.
P2860
Q26764979-05F3F0DD-82DB-427F-A8A6-9EB4DA359490Q34007433-3E23277C-F377-46D4-8F36-ED8F770CAD42Q34319379-027DADED-6265-491E-9B1A-02E52AAD54A7Q34437626-8176CF4C-592C-414D-9674-9691AD068B16Q34794244-492A0C7E-A8E5-45B8-BD7B-18FBBA86C901Q34991022-B006525F-A952-4FC6-9E7A-EA305ABA879EQ35232801-F19A753A-1231-4B2A-A1A1-FED915A88801Q36373260-D4B63FE7-BCA6-4140-AA79-76AB4E49A1FBQ36547324-43AFDD27-B89C-41D5-8104-A95872D9319DQ36603325-F88DDB57-4327-4A3F-80C0-CDC950D8E236Q36899987-EDF41C72-643B-43B0-A895-641DFBBAE7A4Q37512939-3E84563D-5F90-41B0-A5B0-762130D2386CQ38560170-0F509FD7-034D-4C0B-8BB1-44AC3010183AQ38736019-D26A2926-C179-46CB-992C-CAF542EEB393Q38860948-90047BD1-129F-4713-9637-036B1936FC4FQ39912221-CD9990D0-8BD9-4032-A769-73F2BD5454FCQ40136026-EE4A44DF-62F5-4FBB-866D-C87D8FEEE023Q40156701-67803681-C1CB-42B3-94B7-5C37594ADCC0Q40285941-46BE897A-1C80-4839-861D-978C08372467Q40318619-BA65FFD2-62E3-47C4-99BA-2672AD8D9604Q40779986-8720F581-F6C4-473C-A232-67C5DDAD4A94Q41919271-86FD6F4F-32CB-42C8-98B8-B2EDE645EF2FQ42270490-41D2F022-1F8D-4937-87B1-895F8E23A6C4Q47582990-870B3692-9E70-4E08-8EDF-0117F356369FQ48294788-2E03F6F1-45E2-4716-A5BA-ED1C21E479B1Q55080512-27471ED9-97A4-46C9-BC0B-9B4E540B788C
P2860
Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Higher risk of measles when th ...... onths versus 15 months of age.
@en
Higher risk of measles when th ...... onths versus 15 months of age.
@nl
type
label
Higher risk of measles when th ...... onths versus 15 months of age.
@en
Higher risk of measles when th ...... onths versus 15 months of age.
@nl
prefLabel
Higher risk of measles when th ...... onths versus 15 months of age.
@en
Higher risk of measles when th ...... onths versus 15 months of age.
@nl
P2093
P2860
P356
P1476
Higher risk of measles when th ...... months versus 15 months of age
@en
P2093
Brian J Ward
Danuta M Skowronski
Fannie Defay
Fernand Guillemette
Julio Soto
Manale Ouakki
Mélanie Benoît
Nicole Boulianne
Sylvie Lacoursière
P2860
P304
P356
10.1093/CID/CIS439
P407
P577
2012-04-27T00:00:00Z